Galapagos | Lucro Operacional



Operating Profit Alterar Data
argenx SE USD 203.84M 64.9M 2025-06
AstraZeneca USD 3.51B 166M 2025-06
Biogen USD 851.8M 540.6M 2025-06
Genmab DKK 360M 172M 2025-06
Gilead Sciences USD 2.7B 467M 2025-06
GlaxoSmithKline GBP 2.02B 193M 2025-06
GRIFOLS EUR 349.54M 80.68M 2025-06
Hikma Pharmaceutical USD 282M 45M 2024-12
Incyte USD 310.82M 105.66M 2025-06
Merck EUR 1.03B 24M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
Novartis USD 4.86B 201M 2025-06
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 1.71B 573M 2025-06
UCB EUR 1B 678M 2024-12
Vertex Pharmaceuticals USD 1.15B 123.1M 2025-06


Galapagos Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Sep 2025.